QualityDipStocks / Health Care · Medical Specialities
Lumexa Imaging LMRI
Outside our quality screen, so we don’t track its dips. It’s 40% below its 52-week high.
Outside our quality screen. No fair value estimate for now: there isn’t enough data.
- Fair value est.
- n/a
- Market Value
- —
- Off 52-wk high
- −40%
- Risk vs market
- Above marketbeta 1.48
52-week range 37% of the way from its 52-week low to its high
Price $11.15
0 bullish · 3 bearish See why
Valuation
What we estimate it's worth, and how it ranks on value vs every stock we cover.
Fair value estimate
No estimate for LMRI: Capital spending isn't tagged for the latest period in SEC XBRL data. We’d rather show nothing than a made-up number.
Risk vs market
How risk vs market is measured
One year of daily returns (Dec 12 to Nov 2, 223 sessions). Beta = how much LMRI moved for each 1% move in the S&P 500 (SPY); 1.0 moves with the market. Volatility is the yearly standard deviation of daily returns. Past behavior, not a forecast.
Swings more than the market, and its own price swings are 5.9× the S&P 500’s.
- Beta vs S&P 500
- 1.48
- Volatility
- 75% vs 13% SPY
- Correlation SPY
- 0.25
- Correlation QQQ
- 0.19
Valuation details
Fundamentals
The business itself: sales, profits, cash and debt, from SEC filings.
Bull vs bear
Rule-based from the data on this page, strongest first. Not advice.
Top bullish points 0 of 5
Nothing in our data makes a clear bull case right now.
Top bearish points 3 of 5
Balance sheetNet debt is 11.6× a year of EBITDA, a heavy load.
QualityDoesn’t pass our quality screen: no positive free cash flow; ROE under 12% and ROIC under 10%; net debt 11.6× EBITDA (limit 3×).
RiskReports earnings Nov 10 (consensus EPS $0.07): results can move the price sharply and reset Market Value.
All fundamentals
from SEC filings
No fundamentals for Lumexa Imaging: Newly registered with the SEC: too few reported periods yet for trailing-12-month figures (latest 2026-06-30). We show nothing rather than guess.
The business
Sales +5%
- Gross margin15%
- Operating margin3%
- Return on invested capital2%
- Sales growth (latest quarter vs year-ago quarter)+5%
- Net debt / EBITDA11.6×
Chart & levels
Where the price is vs its key levels and trends.
Key levels
Every level vs today’s $11.15
- 52-wk lowlowest close, 1 year$6.77−39.3%
- PriceMon Nov 2 close$11.15you are here
- 52-wk highhighest close, 1 year$18.53+66.2%
Momentum & 52-week range
5 days −5.0%
Signals
Reversal signal setups, the public ledger and the next earnings date.
Setup & signals
No setup armed
No setup armed, so there’s no trigger or stop to track yet. Reversal signal rules only run on companies that pass our quality screen.
Next report
Nov 10
- DateTue Nov 10, after the close
- Consensus EPS$0.07
- Year-ago EPSN/A
- QuarterSep/2026
From Nasdaq’s earnings calendar. A report resets Market Value.
LMRI is outside our quality screen
One text when a published rule fires on one of the 332 quality companies we track: the ticker, the price, the stop and a link to the numbers. Nothing else.
Voices & buzz
Who is talking about it, and how it compares with peers.
Who’s talking about it
Notable investors, executives, analysts and public figures on Lumexa Imaging in the last 48 hours. Headlines as published, each linked. Their words, not ours.
No notable mentions in the last 48 hours. Checked Nov 3, 5:14 PM ET.
Compare with peers
Closest in size in Medical Specialities
Information only, not investment advice. Fair value estimates and talking points are rule-based model output from public data and can be wrong; stop levels are reference points, not orders. How every number is computed.